Our team has a combined 100+ years of experience in managing brands, portfolios, and departments. We provide strategic analyses and recommendations that are both meaningful and actionable. We have been involved in due diligence assessing both drug and diagnostic assets.
We are driven by data, yet leverage our experiences to help guide better decisions. We analyze and interpret your data to make strategic recommendations, providing you the best options to drive value.
Competitive benchmarking
New product planning
Situation analysis
Opportunity assessment
Promotional effectiveness and ROI
Secondary data analysis
Pipeline and portfolio gap analysis
Asset prioritization
